Neurological functions of the masterswitch protein kinase - GSK-3

Frontiers in Molecular Neuroscience

Volumn , Issue MARCH, 2012, Pages 1-5

  Kaidanovich Beilin, Oksana ^a   Beaulieu, Jean Martin ^b   Jope, Richard Scott ^c   Woodgett, James Robert ^a,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; LITHIUM; PROTEIN SERINE KINASE; SEROTONIN; TAU PROTEIN; TAU PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN TUMOR; CATALYSIS; FRAGILE X SYNDROME; GLYCOGEN SYNTHESIS; METABOLIC REGULATION; NONHUMAN; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84859331841     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00048     Document Type: Article

References (22)

1. Beaulieu, J. M., Del'guidice, T., Sotnikova, T. D., Lemasson, M. and Gainetdinov, R. R. (2011) Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci, 4, 38.
2. Beurel, E. (2011) Regulation by Glycogen Synthase Kinase-3 of inflammation and T cells in CNS diseases. Front Mol Neurosci, 4, 18.
3. Bradley, C. A., Peineau, S., Taghibiglou, C., Nicolas, C. S., Whitcomb, D. J., Bortolotto, Z. A., Kaang, B. K., Cho, K., Wang, Y. T. and Collingridge, G. L. (2012) A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci, 5, 13.
4. Chuang, D. M., Wang, Z. and Chiu, C. T. (2011) GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci, 4, 15.
5. Cole, A. R. (2012) GSK3 as a sensor determining cell fate in the brain. Front Mol Neurosci, 5, 4.
6. Eldar-Finkelman, H. and Martinez, A. (2011) GSK-3 inhibitors: preclinical and clinical focus on CNS. Front Mol Neurosci, 4, 32.
7. Emamian, E. S. (2012) AKT/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci, 5, 33.
8. Freland, L. and Beaulieu, J. M. (2012) Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci, 5, 14.
9. Gomez-Sintes, R., Hernandez, F., Lucas, J. J. and Avila, J. (2011) GSK-3 mouse models to study neuronal apoptosis and neurodegeneration. Front Mol Neurosci, 4, 45.
10. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P. and Anderton, B. H. (1992) Glycogen Synthase Kinase-3 induces Alzheimer's disease-like phosphorylation of Tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett, 147, 58-62.
11. Jope, R. S. (2011) Glycogen Synthase Kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci, 4, 16.
12. Kaidanovich-Beilin, O. and Woodgett, J. R. (2011) GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci, 4, 40.
13. Kim, W. Y. and Snider, W. D. (2011) Functions of GSK-3 signaling in development of the nervous system. Front Mol Neurosci, 4, 44.
14. Kim, Y. T., Hur, E. M., Snider, W. D. and Zhou, F. Q. (2011) Role of GSK3 signaling in neuronal morphogenesis. Front Mol Neurosci, 4, 48.
15. Kremer, A., Louis, J. V., Jaworski, T. and Van Leuven, F. (2011) GSK3 and Alzheimer's Disease: facts and fiction. Front Mol Neurosci, 4, 17.
16. Medina, M., Garrido, J. J. and Wandosell, F. G. (2011) Modulation of GSK-3 as a therapeutic strategy on Tau pathologies. Front Mol Neurosci, 4, 24.
17. Mills, C. N., Nowsheen, S., Bonner, J. A. and Yang, E. S. (2011) Emerging roles of Glycogen Synthase Kinase 3 in the treatment of brain tumors. Front Mol Neurosci, 4, 47.
18. Mines, M. A. and Jope, R. S. (2011) Glycogen Synthase Kinase-3: a promising therapeutic target for Fragile X syndrome. Front Mol Neurosci, 4, 35.
19. Polter, A. M. and Li, X. (2011) Glycogen Synthase Kinase-3 is an intermediate modulator of serotonin neurotransmission. Front Mol Neurosci, 4, 31.
20. Takahashi, M., Tomizawa, K., Kato, R., Sato, K., Uchida, T., Fujita, S. C. and Imahori, K. (1994) Localization and developmental changes of Tau Protein Kinase I/Glycogen Synthase Kinase-3 Beta in rat brain. J Neurochem, 63, 245-55.
21. Takashima, A. (2012) GSK-3 and memory formation. Front Mol Neurosci, 5, 47.
22. Valvezan, A. J. and Klein, P. S. (2012) GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front Mol Neurosci, 5, 1.